Anticancer online medicine | Millionpharma

PIRFENEX Description: pirfenex  contain pirfenidon as an active ingredient. Pirfenex is orally active small molecule drugs that may inhibit collagen synthesis, down regulate production of multiple cytokines and block fibroblast proliferation and stimulation in response to cytokines.  pirfenex tablet pirfenex  has demonstrated activity in multiple fibrotic conditions, including those of the lung, kidney and liver. It is being investigated by intermune. pirfenex , pirfenex tablet , pirfenex price in india , pirfenex side effects , pirfenex uses pirfenex, pirfenex tablet Mode of action pirfenex  is an orally active, small molecule that shows a wide range of biologic activity. In vitro evidence has shown that Pirfenex inhibits collagen synthesis,  pirfenex  down-regulates profibrotic cytokines and decreases fibroblast proliferation. pirfenex  leads to a reduction of tgf-beta2 mRNA levels and of the mature tgf-beta2 protein due to decreased expression and direct inhibiti

tafero,tafero таблетка,tafero 25mg,tafero 25mg таблетка  TAFERO tafero,tafero 25mg,tafero таблетка,tafero 25mg таблетка ОПИСАНИЕ Тенофовир  tafero 25mg таблетка  Алафенамид е антихепацивирусно и антиретровирусно лекарство. При пациенти, заразени с HIV, Tafero не се използва самостоятелно и може да се комбинира с други антиретровирусни лекарства като Emtricitabine, cobicistat или дарунавир.  tafero На първо място, Tafero принадлежи към антиретровирусен (нуклеозиден инхибитор на обратната транскриптаза), сега Tafero притежава антихепацивирусно свойство, което се използва срещу вирусна инфекция с хепатит B  tafero ПОТРЕБИТЕЛИ НА TAFERO Преди употреба на  tafero 25mg таблетка  таблетка, използвана при инфекция с HIV-1 Таферо таблетката е показана също за лечение на вирусна инфекция с хепатит B, като намалява развитието на вируса Tafero, използван при хронична хепатит B инфекция, но не може да се предотврати предаването на вируса  tafero КАК ДА ПРИЕМАТЕ TAFERO TABLET О

Thanks A Lord For Publish In Your Blog, This Is A Great Things To Learned Many Information. Keep Posting Many Blogs Like This. <a href="https://beemainfratech.com">scaffolding dealers in chennai,aluminium scaffolding dealers in chennai</a>

                                         POMALID 1MG pomalid 1mg,pomalid 1mg capsules,pomalid 1mg price in india,pomalid 1mg side effects,pomalid 1mg uses                                                      DESCRIPTION Drug profile Pomalid 1mg Contain Pomalidomide, Pomalid 1Mg capsule used along with dexamethasone to treat a type of cancer known as multiple myeloma. Mode Of Action Pomalid 1Mg Capsules Is In A Class of medication called immunomodulatory agents. It works by helping the bone marrow to produce normal blood cells and by killing abnormal cells in the bone marrow. Dosage The Recommended Dose Of Pomalidomide is 2Mg once Daily orally on Daily, until disease progression. Pomalidomide should be given in the combination of Dexamethasone. Pomalid 1mg may be taken with water, inform patient not to break ,chew,or open the capsule. Pomalid 1mg price in india may be talken with or without food. How To Take Pomalidomide Pomalid 1Mg Available In three Strength

POMYELO 4MG MULTIPLE MYELOMA DESCRIPTION Pomalidomide is sold under the brand name Pomyelo 4mg and it belongs to anti-neoplastic drugs Pomyelo 4mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomyelo 4mg c ombination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomyelo 4mg capsules is used in the treatment of Multiple Myeloma condition. In this condition, Pomyelo 4mg capsules is used by combining with dexamethasone. Pomyelo 4mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomyelo 4mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomyelo has three primary pharmacological

BEVATAS GLIOBLASTOMA MULTIFORME DESCRIPTION Bevacizumab is a drug sold under the name of Bevatas and which is categorized as monoclonal anti-body & anti-angiogenesis  When Bevatas 100mg concomitant use with human monoclonal antibody IgG1, that circumstance and prohibits the biological action of human vascular endothelial growth factor (VEGF) USAGE Bevatas 100mg is indicated for the treatment of some of the conditions like Metastatic colon or rectal cancer Non-squamous, non-small cell lung cancer Glioblastoma Metastatic renal cell cancer Metastatic cervical cancer Epithelial ovarian, fallopian tube or peritoneal cancer MECHANISM OF ACTION Bevatas 100mg Injection comprises an active compound like Bevacizumab which binds to VEGF and avoid the communication of VEGF to its receptors like Flt-1 & KDR) present on the surface of the cells This interaction prevents endothelial cell multiplication and new blood vessel production occurs Hence in counts cessation

POMAHOPE 4MG MULTIPLE MYELOMA DESCRIPTION Pomalidomide is sold under the brand name Pomahope 4mg and it belongs to anti-neoplastic drugs Pomahope 4mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomahope 4mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomahope 4mg is used in the treatment of Multiple Myeloma condition. In this condition, Pomahope 4mg Capsules is used by combining with dexamethasone. Pomahope 3mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomahope 4mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomahope has three primary pharmacological activi

POMAHOPE 3MG MULTIPLE MYELOMA DESCRIPTION Pomalidomide is sold under the brand name Pomahope 3mg and it belongs to anti-neoplastic drugs Pomahope 3mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomahope 3mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomahope 3mg is used in the treatment of Multiple Myeloma condition. In this condition, Pomahope 3mg capsules is used by combining with dexamethasone. Pomahope 3mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomahope 3mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomahope has three primary pharmacological activi

POMAHOPE 2MG MULTIPLE MYELOMA DESCRIPTION Pomalidomide is sold under the brand name Pomahope 2mg and it belongs to anti-neoplastic drugs Pomahope 2mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomahope 2mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomahope 2mg is used in the treatment of Multiple Myeloma condition. In this condition, Pomahope 2mg is used by combining with dexamethasone. Pomahope 2mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomahope 2mg capsules treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomahope has three primary pharmacological activitie

POMAHOPE 1MG POMAHOPE 1MG DESCRIPTION Pomalidomide is sold under the brand name Pomahope 1mg and it belongs to anti-neoplastic drugs Pomahope 1mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomahope 1mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomahope 1mg capsules is used in the treatment of Multiple Myeloma condition. In this condition, Pomahope 1mg capsules is used by combining with dexamethasone. Pomahope 1mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomahope 1mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomahope has three primary pharmacological ac

ZELGOR 500MG PROSTATE CANCER DESCRIPTION Zelgor 500mg is belongs to anti neoplastic drugs which will work by Diminish the androgen production in the body. Androgen is a male hormone which balances the cancer cell in prostate glands. Normally this tablet is taken by combination with prednisolone, a steroid which decreases the liability of side effects produced by Abiraterone. MECHANISM OF ACTION Androgens are regulating the production of tumors in prostate. Zelgor 500mg is an anti-androgen drugs, which causes to eradicate the enzyme 17α-hydroxylase C 17, 20-lyase (CYP17), it is includes in androgen synthesis. Decrease the serum testosterone level. Diminished the tumor cell occurred. Brand :Zelgor Ingredients : Abiraterone acetate Strength : 500mg Manufactured : Sun Pharmaceuticals Ltd Package : 60 tablets PHARMACOKINETICS Absorption of tablet Zelgor 500mg:   Time to median plasma concentration of tablet Zelgor 500mg takes 12 hours. Distribution

ZELGOR PROSTATE CANCER DESCRIPTION Zelgor 250mg is belongs to anti neoplastic drugs which will work by Diminish the androgen production in the body. Androgen is a male hormone which balances the cancer cell in prostate glands.  Normaly this tablet is taken by combination with prednisolone, a steroid which decreases the liability of side effects produced by Abiraterone. MECHANISM OF ACTION Androgens are regulates the production of tumors in prostate. Zelgor 250mg tablet is an anti androgen drugs, which causes to eradicate the enzyme 17α-hydroxylase C 17, 20-lyase (CYP17), it is includes in androgen synthesis. Decrease the serum testosterone level. Diminished the tumor cell occurred. PHARMACOKINETICS ABSORPTION Time to median plasma concentration of tablet Zelgor 250mg takes 12 hours. DISTRIBUTION Maximum bound to the human plasma protein like albumin and alpha-1 acid glycoprotein. METABOLISM The main two metabolites of Abiraterone in human plasma are

ZECYTE 500MG PROSTATE CANCER DESCRIPTION Zecyte 500mg is belongs to anti neoplastic drugs which will work by Diminish the androgen production in the body. Androgen is a male hormone which balances the cancer cell in prostate glands. Normally this tablet is taken by combination with prednisolone, a steroid which decreases the liability of side effects produced by Abiraterone. MECHANISM OF ACTION Androgens are regulating the production of tumors in prostate. Zecyte 500mg is an anti-androgen drugs, which causes to eradicate the enzyme 17α-hydroxylase C 17, 20-lyase (CYP17), it is includes in androgen synthesis. Decrease the serum testosterone level. Diminished the tumor cell occurred. Brand :Zecyte Ingredients : Abiraterone acetate Strength : 500mg Manufactured : Glenmark Pharmaceuticals Ltd Package : 60 tablets PHARMACOKINETICS Absorption of tablet Zecyte 500mg Tablets :  Time to median plasma concentration of tablet Zecyte 500mg takes 12 hours. 

ZECYTE PROSTATE CANCER DESCRIPTION Zecyte 250mg is belongs to anti neoplastic drugs which will work by Diminish the androgen production in the body. Androgen is a male hormone which balances the cancer cell in prostate glands.  Normaly this tablet is taken by combination with prednisolone, a steroid which decreases the liability of side effects produced by Abiraterone. MECHANISM OF ACTION Androgens are regulates the production of tumors in prostate. Zecyte 250mg tablet is an anti androgen drugs, which causes to eradicate the enzyme 17α-hydroxylase C 17, 20-lyase (CYP17), it is includes in androgen synthesis. Decrease the serum testosterone level. Diminished the tumor cell occurred. PHARMACOKINETICS ABSORPTION Time to median plasma concentration of tablet Zecyte 250mg takes 12 hours. DISTRIBUTION Maximum bound to the human plasma protein like albumin and alpha-1 acid glycoprotein. METABOLISM The main two metabolites of Abiraterone in human plasma are

ABIRAPRO 500MG PROSTATE CANCER DESCRIPTION Abirapro 500mg is belongs to anti neoplastic drugs which will work by Diminish the androgen production in the body. Androgen is a male hormone which balances the cancer cell in prostate glands. Normally this tablet is taken by combination with prednisolone, a steroid which decreases the liability of side effects produced by Abiraterone. MECHANISM OF ACTION Androgens are regulating the production of tumors in prostate. Abirapro 500mg is an anti-androgen drugs, which causes to eradicate the enzyme 17α-hydroxylase C 17, 20-lyase (CYP17), it is includes in androgen synthesis. Decrease the serum testosterone level. Diminished the tumor cell occurred. Brand :Abirapro Ingredients : Abiraterone acetate Strength : 500mg Manufactured : Glenmark Pharmaceuticals Ltd Package : 60 tablets PHARMACOKINETICS Absorption of tablet Abirapro 500mg tablet :  Time to median plasma concentration of tablet Abirapro 500mg takes 12

ABIRAPRO PROSTATE CANCER DESCRIPTION Abirapro 250mg is belongs to anti neoplastic drugs which will work by Diminish the androgen production in the body. Androgen is a male hormone which balances the cancer cell in prostate glands.  Normaly this tablet is taken by combination with prednisolone, a steroid which decreases the liability of side effects produced by Abiraterone. MECHANISM OF ACTION Androgens are regulates the production of tumors in prostate. Abirapro 250mg is an anti androgen drugs, which causes to eradicate the enzyme 17α-hydroxylase C 17, 20-lyase CYP17), it is includes in androgen synthesis. Decrease the serum testosterone level. Diminished the tumor cell occurred. PHARMACOKINETICS ABSORPTION Time to median plasma concentration of tablet Abirapro 250mg tablet takes 12 hours. DISTRIBUTION Maximum bound to the human plasma protein like albumin and alpha-1 acid glycoprotein. METABOLISM The main two metabolites o